Spokane, Wash.-based biotech startup Iasis Molecular Sciences received a $1.25 million grant from a U.S. government program that addresses spinal cord injuries. The 7-year old company will develop a “wholly antimicrobial” urinary catheter that incorporates the company’s proprietary antimicrobials throughout its structure, instead of just as a coating. Founder and CEO David Vachon...
Antimicrobial biotech startup lands $1.25M grant to develop urinary catheter
Source: Pinoy Big Sister PH
0 Mga Komento